Sandoz Group AG

Sandoz Group AG

SDZNY
Sandoz Group AGUS flagOther OTC
79.34
USD
-0.43
- -
34.33BMarket Cap
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
21.59
23.21
24.14
- -
Basic EPS, GAAP
1.97
0.18
- -
- -
Free Cash Flow per Basic Share
1.85
-0.61
0.14
- -
Dividend per Share
- -
- -
0.5
- -
Book Value per Share
20.3
0.06
0.06
- -
Tangible Book Value per Share
-0.3
-1.16
-1.81
- -
Basic Weighted Avg Shares
431
430
430
- -
Sales/Revenue/Turnover
9,306
9,979
10,384
11,157
Operating Margin (%)
13.31
3.76
2.96
12.77
Depreciation Expense
492
525
502
545
Net Income, GAAP
848
77
- -
914
Effective Tax Rate (%)
22.87
38.46
- -
24.28
Profit Margin (%)
9.11
0.77
- -
8.19
Working Capital
-1,938
1,874
1,494
1,270
LT Debt
118
4,230
4,666
5,010
Total Equity
8,760
8,654
8,164
9,385
Return on Invested Capital (%)
- -
1.98
- -
7.32
Return on Capital (%)
- -
2.9
- -
20.41
Return on Common Equity (%)
- -
1.76
- -
3,656

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
14.96%
Free Cash Flow
- -
- -
1,250%
Net Income, GAAP
- -
- -
1,087.01%
Sales/Revenue/Turnover
- -
- -
7.44%
Total Cash Common Dividend
- -
- -
46.51%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
9,979
2024
- -
- -
- -
- -
10,384
2025
- -
- -
- -
- -
11,157

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.18
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
0.5
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Richard Saynor
Full Time Employees
22,049
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
Suurstoffi 14 Rotkreuz Switzerland 6343
IPO Date
Oct 4, 2023
Website
sandoz.com
Business
Sandoz Group AG operates as a prominent global entity in the realm of generic medications and biosimilars. The company is dedicated to the creation, production, and worldwide distribution of accessible, high-quality pharmaceutical products. Its portfolio encompasses a wide array of generic small-molecule medicines and complex biosimilar alternatives across various therapeutic categories, including cardiovascular, oncology, and central nervous system disorders. Sandoz also delivers active pharmaceutical ingredients and finished dose forms, particularly emphasizing its extensive range of anti-infectives, such as antibiotics. The organization spun off to become an independent public company in October 2023. Established in 1886, Sandoz maintains its headquarters in Basel, Switzerland.

Company News

APIChat
  • Generic drugmaker Sandoz files anti-dumping complaint about Chinese antibiotics imports

  • Sandoz Group AG Sponsored ADR (SDZNY) Upgraded to Buy: Here's What You Should Know

  • USNA or SDZNY: Which Is the Better Value Stock Right Now?

  • Sandoz CEO Says Size of Weight-Loss Generics Market Is Unknown

  • Sandoz Group AG (SDZNY) Q1 2026 Sales/Trading Call Transcript

  • USNA vs. SDZNY: Which Stock Is the Better Value Option?

  • All You Need to Know About Sandoz Group AG Sponsored ADR (SDZNY) Rating Upgrade to Buy

  • SGIOY vs. SDZNY: Which Stock Is the Better Value Option?

  • Sandoz Group (OTCMKTS:SDZNY) Trading Down 1.7% – Should You Sell?

  • SGIOY vs. SDZNY: Which Stock Should Value Investors Buy Now?

  • 3 Generic Drug Stocks to Watch Despite Industry Headwinds

  • Sandoz Shares Jump on Improved Guidance

  • Sandoz Group AG (SDZNY) Q4 2025 Earnings Call Transcript

  • SGIOY or SDZNY: Which Is the Better Value Stock Right Now?

  • Sandoz: The Share Price May Have Run Its Course

  • Sandoz Group (OTCMKTS:SDZNY) versus Context Therapeutics (NASDAQ:CNTX) Head-To-Head Contrast

  • Sandoz Group AG (SDZNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

  • Financial Comparison: Daiichi Sankyo (OTCMKTS:DSNKY) vs. Sandoz Group (OTCMKTS:SDZNY)

  • Sandoz Group (OTCMKTS:SDZNY) Trading Up 3.3% – What’s Next?

  • SDZNY vs. STVN: Which Stock Is the Better Value Option?